Ti-Com
Brain diseases are elusive therapeutic targets. Neurointerventions still lack an adequate level of precision to meet a demand for personalized treatments. This is evident both at the start in animal studies, and at the clinical finish. Ti-com builds on the academic heritage of its owners. We offer an expertise in the field of precision drug delivery to the brain under image guidance. We specialize in highly clinically relevant large animal models of stroke, brain cancer and other neurological diseases. Our experimental approaches fit into the precision medicine paradigm for testing the safety and efficacy of therapeutic agents and devices.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Ti-Com
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- DG
Dominika Gołubczyk
CEO · General Business & Management
EmailPhone - PW
Piotr Walczak
Co-owner · General Business & Management
EmailPhone
Showing 2 of 4 verified contacts
Top roles at Ti-Com
3 distinct titles indexed · top 3 shown.
- 2cfo shareholder
- 1ceo
- 1co-owner
Sign up to unlock all 4 contacts at Ti-Com
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Ti-Com
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.